Skip to main content

Day: April 8, 2025

22nd Century CEO & Chairman Larry Firestone Provides Corporate Update Letter to Stockholders

Corporate Update Letter Highlights Plans to Begin Profitable Growth Phase in 2025 on Expansion of Rebranded VLN® Cigarette Products MOCKSVILLE, N.C., April 08, 2025 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today issued the following letter to stockholders from Larry Firestone, the Chief Executive Officer of 22nd Century Group, Inc.: A Letter to Our Shareholders From Larry Firestone, CEO & Chairman – 22nd Century Group It’s been 16 months since I stepped into the role of Chairman and CEO, and I’ve never been more energized by the mission we’re driving forward together. Before diving into this update, I want to take a moment to express my genuine appreciation to every member...

Continue reading

Beat the April 15 Tax Deadline, But Don’t Leave Money Behind

H&R Block provides expert advice to help last-minute tax filers get the max refund KANSAS CITY, Mo., April 08, 2025 (GLOBE NEWSWIRE) — With the deadline to file taxes only 7 days away, H&R Block (NYSE: HRB), the company that pioneered the tax prep category 70 years ago, is providing crucial last-minute tips to help taxpayers navigate the final stretch of tax season while ensuring no dollar is left behind. According to IRS data, 2025 filings are slightly lower compared to last year1, which means millions of taxpayers will be scrambling to meet the April 15th deadline. “Each year, millions of taxpayers leave billions of dollars behind because they miss valuable deductions and credits they’re entitled to,” said Andy Phillips, Vice President of The Tax Institute at H&R Block. “Filing taxes can be stressful, especially...

Continue reading

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting

NeuroPace RNS SystemNeuroPace RNS SystemThree-year data from the largest FDA-reviewed prospective neuromodulation study of safety and effectiveness in drug-resistant focal epilepsy1 Long-term seizure reduction with a median reduction of 82% at 3 years. Seizure freedom with 42% of patients remaining seizure free for 6+ months.iMOUNTAIN VIEW, Calif., April 08, 2025 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced three-year effectiveness data from the Post-Approval Study (PAS) of the RNS® System, which showed an 82% median reduction in seizures in adults treated with brain-responsive stimulation for drug-resistant focal epilepsy (DRE).1 The data were presented in an oral presentation at the American Academy of...

Continue reading

Clean Earth Rolls Out New Fleet Nationwide, Enhancing Sustainability and Service Efficiency

Clean Earth TrucksNew trucks feature innovative modular design and technology-driven advancements, enhancing safety, compliance, and customer service.New trucks feature innovative modular design and technology-driven advancements, enhancing safety, compliance, and customer service.KING OF PRUSSIA, Pa., April 08, 2025 (GLOBE NEWSWIRE) — Clean Earth, a division of Enviri Corporation (NYSE: NVRI) and a leading provider of environmental and regulated waste management services, announced the recent deployment of a new fleet of 132 Class 7 and Class 8 straight trucks across the U.S. and U.S. territories. The fleet’s advanced features reduce environmental impact, boost efficiency, and enhance service reliability for Clean Earth’s retail and healthcare customers and are designed to securely transport hazardous, non-hazardous,...

Continue reading

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a study published in The Journal of Molecular Diagnostics that describes a method for analysis of multiple myeloma (MM) by optical genome mapping (OGM). MM is one of the most common blood cancers, or hematologic malignancies, and is understood to be a difficult sample to analyze using traditional cytogenetics. Direct analysis of MM samples, by methods such as FISH or OGM, can be problematic because it is challenging to isolate enough cells with a known MM marker (CD138) on their surface, so-called CD138-positive cells. In this paper, researchers at Institute of Medical Genetics, Lille University Hospital, Lille, France, have described a method for OGM that can overcome the hurdle of limited sample quantity and can cut in half the...

Continue reading

ProStar Announces Global Commercial Strategy with Radiodetection to Deliver Precision Utility Mapping

GRAND JUNCTION, Colo., April 08, 2025 (GLOBE NEWSWIRE) — ProStar® Holdings Inc., (“ProStar®” or “the Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00) the developers of PointMan®, Precision Mapping Solutions® is pleased to announce a Global Commercial Strategy with Radiodetection, a world leader in utility locating equipment and a subsidiary of SPX Technologies (NYSE: SPXC),. This strategic collaboration combines Radiodetection’s RD82 series locating devices with PointMan to create a powerful and integrated solution for the global critical buried infrastructure industry. To read the original news release from Radiodetection, click here. A Powerful Approach to Subsurface Infrastructure Mapping With operations in over 60 countries, Radiodetection is a world leader in the management of critical infrastructure and utilities that provides...

Continue reading

American Oncology Network Value-Based Care Director Anne Marie Rainey Appointed to ACCC Board of Trustees

FORT MYERS, Fla., April 08, 2025 (GLOBE NEWSWIRE) — American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced that Anne Marie Rainey, AON’s director of value-based care, has been appointed to the Association of Cancer Care Centers’ Board of Trustees.As director of value-based care at AON, Rainey manages internal quality, government, and value-based care initiatives. She has experience in government quality reporting as a contractor for the Centers for Medicare & Medicaid Services and the Centers for Disease Control and Prevention. After earning her Master of Science in Nursing in leadership and administration, she transitioned to community oncology, where she focuses on quality metrics analysis, program implementation, health policy, and community oncology advocacy. “I...

Continue reading

FTC Solar Introduces Revolutionary Dual-Row Configuration for 1P Pioneer Tracker™: Industry’s Highest East-West Slope Tolerance for a linked tracker

AUSTIN, Texas, April 08, 2025 (GLOBE NEWSWIRE) — FTC Solar, a leading provider of cutting-edge solar tracker technology, is excited to unveil its latest innovation with the dual-row configuration for the 1P Pioneer Tracker™, setting a new standard in efficiency and adaptability for solar installations. Designed to meet the demands of challenging terrain, FTC’s dual-row system significantly enhances project yield, reduces costs, and maximizes land utilization. With unmatched East-West slope tolerance and customizable options, the dual-row configuration of the 1P Pioneer Tracker™ provides developers and EPCs with a versatile solution for navigating complex project landscapes. Key Features of the Dual-Row ConfigurationIndustry-Leading East-West Slope Tolerance of 17.5%FTC Solar’s dual-row design offers the industry’s...

Continue reading

Sysco to Announce Third Quarter Fiscal Year 2025 Financial Results on April 29

HOUSTON, April 08, 2025 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) will host a conference call and webcast to discuss its third quarter fiscal year 2025 financial results at 10 a.m. EDT on Tuesday, April 29, 2025. All interested parties are invited to listen online at investors.sysco.com. Prior to the conference call and webcast, the company will also issue a news release and post a slide presentation in the investor relations section of its website. A replay of the webcast will be available online shortly after the live webcast is completed. For purposes of public disclosure, including this and future similar events, Sysco uses the investor relations section of its website, found at investors.sysco.com, as the primary channel for publishing key information to its investors, some of which may contain material and previously...

Continue reading

Nano Dimension Appoints Ofir Baharav as CEO

Mr. Baharav to Drive Critical Desktop Metal and Markforged Strategic Integration Towards Growth Outlook that Can Deliver Financial Results Robert Pons to Become Chairman of the Board Waltham, Massachusetts, April 08, 2025 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM), a digital manufacturing leader, today announced the appointment of Mr. Ofir Baharav as its new Chief Executive Officer, effective immediately. This strategic move underscores the Company’s commitment to swiftly realizing merger synergies, restoring profitability, and delivering substantial shareholder value. The Board of Directors, having worked closely with Mr. Baharav as Chairman, recognized his unique qualifications. Mr. Baharav has a proven track record in transformation and innovation, along with a deep background in capital equipment for the electronics...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.